Global Protein Engineering Market to Reach $7.8 Billion by 2030
The global market for Protein Engineering estimated at US$3.1 Billion in the year 2022, is projected to reach a revised size of US$7.8 Billion by 2030, growing at a CAGR of 12.4% over the analysis period 2022-2030. Instruments, one of the segments analyzed in the report, is projected to record 11.5% CAGR and reach US$3.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 12.6% CAGR for the next 8-year period.The U.S. Market is Estimated at $835.9 Million, While China is Forecast to Grow at 18.2% CAGR
The Protein Engineering market in the U.S. is estimated at US$835.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2030 trailing a CAGR of 18.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 9.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.Select Competitors (Total 18 Featured) -
- Abzena, Ltd.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Codexis, Inc.
- Creative Biolabs
- Danaher Corporation
- Enantis S.R.O.
- GE Healthcare
- Genscript Biotech Corporation
- Innovagen AB
- Merck KGaA
- New England Biolabs, Inc.
- Perkinelmer, Inc.
- Phynexus, Inc. (A Part of Biotage)
- Promega Corporation
- Proteogenix
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
- Waters Corporation
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abzena, Ltd.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Codexis, Inc.
- Creative Biolabs
- Danaher Corporation
- Enantis S.R.O.
- GE Healthcare
- Genscript Biotech Corporation
- Innovagen AB
- Merck KGaA
- New England Biolabs, Inc.
- Perkinelmer, Inc.
- Phynexus, Inc. (A Part of Biotage)
- Promega Corporation
- Proteogenix
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
- Waters Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 81 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 3.1 Billion |
Forecasted Market Value ( USD | $ 7.8 Billion |
Compound Annual Growth Rate | 12.2% |
Regions Covered | Global |